scispace - formally typeset
Search or ask a question
Institution

Solvay

CompanyBrussels, Belgium
About: Solvay is a company organization based out in Brussels, Belgium. It is known for research contribution in the topics: Catalysis & Polymer. The organization has 6083 authors who have published 7004 publications receiving 105745 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: The current dataset provides empirical support for the current clinical consensus that pharmacotherapy of this disorder should be continued beyond the acute phase, and supports the long-term efficacy, safety, and tolerability of fluvoxamine CR in the treatment of GSAD.
Abstract: Fluvoxamine CR has been reported effective in the short-term (12-wk) treatment of generalized social anxiety disorder (social phobia). Social anxiety disorder (SAD) is, however, a chronic disorder thought to require maintenance treatment. We report on data from the extension phase of a short-term study, in order to explore the efficacy and safety profile of fluvoxamine CR (100-300 mg/d) in the longer-term treatment of this disorder. Adult outpatients with generalized social anxiety disorder (GSAD) at 35 centres in Europe, South Africa, and USA were included in an acute phase study (12 wk). Subjects who demonstrated at least minimal improvement by endpoint (n=112), were offered participation in an extension phase, in which medication was continued for a further 12 wk under double-blind conditions. Efficacy was assessed using the Liebowitz Social Anxiety Disorder Scale (LSAS), the Clinical Global Impression Global Improvement score (CGI-I), the Clinical Global Impressions Severity of Illness score (CGI-S), and the Sheehan Disability Scale (SDS). Safety and tolerability assessments were also performed at regular intervals. Subjects treated with fluvoxamine CR had a numerically greater decrease in LSAS total scores than subjects treated with placebo at endpoint. Analysis of data from baseline (day 1) to endpoint (last observation carried forward) demonstrated that this difference tended towards significance, while severity of illness on the CGI-S and disability on the SDS were significantly lower in the fluvoxamine CR group than in the placebo group. The same trends were observed when only data from weeks 12-24 were included in the analysis; although the magnitude of changes was smaller in the extension phase than in the acute phase, fluvoxamine CR-treated subjects continued to show improvement compared to placebo-treated subjects. Most treatment-emergent signs and symptoms (TESS) were mild to moderate in severity. No unexpected abnormalities were reported on vital signs, electrocardiagrams, or laboratory investigations. These data support the long-term efficacy, safety, and tolerability of fluvoxamine CR in the treatment of GSAD. Given the prevalence, persistence, and disability associated with GSAD, and the relative paucity of long-term treatment studies of SAD, the current dataset provides empirical support for the current clinical consensus that pharmacotherapy of this disorder should be continued beyond the acute phase.

42 citations

Patent
Patrick Gilbeau1
19 May 2006
TL;DR: In this article, a method for preparing chlorohydrin which consists in reacting a polyhydroxylated aliphatic hydrocarbon, an ester of a polyhedroxylation alphatic hydrocarbons, or a mixture thereof, with a chlorinating agent to obtain a mixture containing chlorixtures, esters of chlorixtures and water, was described.
Abstract: The invention concerns a method for preparing chlorohydrin which consists in (a) reacting a polyhydroxylated aliphatic hydrocarbon, an ester of a polyhydroxylated aliphatic hydrocarbon, or a mixture thereof, with a chlorinating agent to obtain a mixture containing chlorohydrin, esters of chlorohydrin and water; (b) subjecting at least one fraction of the mixture obtained at step (a) to a distillation and/or stripping treatment to obtain one part concentrated in water, in chlorohydrin and in ester of chlorohydrin; (c) subjecting at least one fraction of the part obtained at step (b) to a separation process in the presence of at least one additive to obtain a portion concentrated in chlorohydrin and in esters of chlorohydrin and which contains less than 40 wt % of water

42 citations

Journal ArticleDOI
I. A. M. de Graaf1, H. J. Koster1
TL;DR: It is concluded that vitrification is the approach that most likely will lead to the development of universal cryopreservation methods for tissue slices of various organs from various animal species.

42 citations

Journal ArticleDOI
TL;DR: Irreversibility for a class of chaotic systems is seen to be an exact consequence of the dynamics through the use of a generalized spectral representation of the time evolution operator of probability densities using a resolvent formalism.
Abstract: Irreversibility for a class of chaotic systems is seen to be an exact consequence of the dynamics through the use of a generalized spectral representation of the time evolution operator of probability densities. The generalized representation is valid for one-dimensional systems when the initial probability density satisfies certain ``physical conditions'' of smoothness. The formalism is first applied to the one-dimensional multi-Bernoulli map, which is a simple map displaying deterministic diffusion. The two-dimensional, invertible baker and multibaker transformations are then studied and the physical conditions determining which discrete spectral values are realized are seen to depend on the smoothness of both the density as well as the observable considered. The generalized representation is constructed using a resolvent formalism. The eigenstates of the diffusive systems are seen to be of a fractal nature.

42 citations

Journal ArticleDOI
23 Jan 2006-Vaccine
TL;DR: Analytical evaluation of the data obtained showed that even exposure during a 2 week period of the vaccine to room temperature would not adversely affect the shelf life claim of the influenza subunit vaccine of 1 year in the refrigerator.

42 citations


Authors

Showing all 6091 results

NameH-indexPapersCitations
Adi F. Gazdar157776104116
Mohammad Khaja Nazeeruddin12964685630
Jack P. Antel10551943950
Philippe Dubois101109848086
Enrico Drioli9598737962
Martin Winter9375145506
Gian F. Giudice9326450392
Johannes Hebebrand9158138408
Michael Graetzel8936043269
Andrew J. Martin8481936203
Alan D. Rogol8146124865
Anthony L. Spek81109059190
William J. Tremaine8028224233
Marc Henneaux7641127840
Stephen Lam7641320693
Network Information
Related Institutions (5)
Centre national de la recherche scientifique
382.4K papers, 13.6M citations

87% related

University of Groningen
69.1K papers, 2.9M citations

87% related

University of Barcelona
108.5K papers, 3.7M citations

86% related

École Normale Supérieure
99.4K papers, 3M citations

85% related

Imperial College London
209.1K papers, 9.3M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20232
202226
2021113
2020159
2019139
2018139